Notch signaling inhibits hepatocellular carcinoma following inactivation of the RB pathway

Patrick Viatour; Ursula Ehmer; Louis A Saddic; Craig Dorrell; Jesper Bøje Andersen; Chenwei Lin; Anne-Flore Zmoos; Pawel K Mazur; Bethany E Schaffer; Austin Ostermeier; Hannes Vogel; Karl G Sylvester; Snorri S Thorgeirsson; Markus Grompe; Julien Sage

doi:10.1084/jem.20110198

Notch signaling inhibits hepatocellular carcinoma following inactivation of the RB pathway

Patrick Viatour, Ursula Ehmer, Louis A Saddic, Craig Dorrell, Jesper Bøje Andersen, Chenwei Lin, Anne-Flore Zmoos, Pawel K Mazur, Bethany E Schaffer, Austin Ostermeier, Hannes Vogel, Karl G Sylvester, Snorri S Thorgeirsson, Markus Grompe, Julien Sage

135 Citations (Scopus)

Abstract

Hepatocellular carcinoma (HCC) is the third cancer killer worldwide with >600,000 deaths every year. Although the major risk factors are known, therapeutic options in patients remain limited in part because of our incomplete understanding of the cellular and molecular mechanisms influencing HCC development. Evidence indicates that the retinoblastoma (RB) pathway is functionally inactivated in most cases of HCC by genetic, epigenetic, and/or viral mechanisms. To investigate the functional relevance of this observation, we inactivated the RB pathway in the liver of adult mice by deleting the three members of the Rb (Rb1) gene family: Rb, p107, and p130. Rb family triple knockout mice develop liver tumors with histopathological features and gene expression profiles similar to human HCC. In this mouse model, cancer initiation is associated with the specific expansion of populations of liver stem/progenitor cells, indicating that the RB pathway may prevent HCC development by maintaining the quiescence of adult liver progenitor cells. In addition, we show that during tumor progression, activation of the Notch pathway via E2F transcription factors serves as a negative feedback mechanism to slow HCC growth. The level of Notch activity is also able to predict survival of HCC patients, suggesting novel means to diagnose and treat HCC.

Original language	English
Journal	The Journal of Experimental Medicine
Volume	208
Issue number	10
Pages (from-to)	1963-76
Number of pages	14
ISSN	0022-1007
DOIs	https://doi.org/10.1084/jem.20110198
Publication status	Published - 26 Sept 2011
Externally published	Yes

Keywords

Animals
Carcinoma, Hepatocellular
Cell Line
Cell Proliferation
E2F Transcription Factors
Gene Expression Profiling
Humans
Liver Neoplasms
Mice
Mice, Inbred C57BL
Mice, Knockout
Microarray Analysis
Receptors, Notch
Retinoblastoma Protein
Signal Transduction
Stem Cells
Transcription, Genetic

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1084/jem.20110198

Cite this

Viatour, P., Ehmer, U., Saddic, L. A., Dorrell, C., Andersen, J. B., Lin, C., Zmoos, A-F., Mazur, P. K., Schaffer, B. E., Ostermeier, A., Vogel, H., Sylvester, K. G., Thorgeirsson, S. S., Grompe, M., & Sage, J. (2011). Notch signaling inhibits hepatocellular carcinoma following inactivation of the RB pathway. The Journal of Experimental Medicine, 208(10), 1963-76. https://doi.org/10.1084/jem.20110198

Viatour, P, Ehmer, U, Saddic, LA, Dorrell, C, Andersen, JB, Lin, C, Zmoos, A-F, Mazur, PK, Schaffer, BE, Ostermeier, A, Vogel, H, Sylvester, KG, Thorgeirsson, SS, Grompe, M & Sage, J 2011, 'Notch signaling inhibits hepatocellular carcinoma following inactivation of the RB pathway', The Journal of Experimental Medicine, vol. 208, no. 10, pp. 1963-76. https://doi.org/10.1084/jem.20110198

@article{aaea701422aa49509ab9ea9ab65d885e,

title = "Notch signaling inhibits hepatocellular carcinoma following inactivation of the RB pathway",

abstract = "Hepatocellular carcinoma (HCC) is the third cancer killer worldwide with >600,000 deaths every year. Although the major risk factors are known, therapeutic options in patients remain limited in part because of our incomplete understanding of the cellular and molecular mechanisms influencing HCC development. Evidence indicates that the retinoblastoma (RB) pathway is functionally inactivated in most cases of HCC by genetic, epigenetic, and/or viral mechanisms. To investigate the functional relevance of this observation, we inactivated the RB pathway in the liver of adult mice by deleting the three members of the Rb (Rb1) gene family: Rb, p107, and p130. Rb family triple knockout mice develop liver tumors with histopathological features and gene expression profiles similar to human HCC. In this mouse model, cancer initiation is associated with the specific expansion of populations of liver stem/progenitor cells, indicating that the RB pathway may prevent HCC development by maintaining the quiescence of adult liver progenitor cells. In addition, we show that during tumor progression, activation of the Notch pathway via E2F transcription factors serves as a negative feedback mechanism to slow HCC growth. The level of Notch activity is also able to predict survival of HCC patients, suggesting novel means to diagnose and treat HCC.",

keywords = "Animals, Carcinoma, Hepatocellular, Cell Line, Cell Proliferation, E2F Transcription Factors, Gene Expression Profiling, Humans, Liver Neoplasms, Mice, Mice, Inbred C57BL, Mice, Knockout, Microarray Analysis, Receptors, Notch, Retinoblastoma Protein, Signal Transduction, Stem Cells, Transcription, Genetic",

author = "Patrick Viatour and Ursula Ehmer and Saddic, {Louis A} and Craig Dorrell and Andersen, {Jesper B{\o}je} and Chenwei Lin and Anne-Flore Zmoos and Mazur, {Pawel K} and Schaffer, {Bethany E} and Austin Ostermeier and Hannes Vogel and Sylvester, {Karl G} and Thorgeirsson, {Snorri S} and Markus Grompe and Julien Sage",

year = "2011",

month = sep,

day = "26",

doi = "10.1084/jem.20110198",

language = "English",

volume = "208",

pages = "1963--76",

journal = "The Journal of Experimental Medicine",

issn = "0022-1007",

publisher = "Rockefeller University Press",

number = "10",

}

TY - JOUR

T1 - Notch signaling inhibits hepatocellular carcinoma following inactivation of the RB pathway

AU - Viatour, Patrick

AU - Ehmer, Ursula

AU - Saddic, Louis A

AU - Dorrell, Craig

AU - Andersen, Jesper Bøje

AU - Lin, Chenwei

AU - Zmoos, Anne-Flore

AU - Mazur, Pawel K

AU - Schaffer, Bethany E

AU - Ostermeier, Austin

AU - Vogel, Hannes

AU - Sylvester, Karl G

AU - Thorgeirsson, Snorri S

AU - Grompe, Markus

AU - Sage, Julien

PY - 2011/9/26

Y1 - 2011/9/26

N2 - Hepatocellular carcinoma (HCC) is the third cancer killer worldwide with >600,000 deaths every year. Although the major risk factors are known, therapeutic options in patients remain limited in part because of our incomplete understanding of the cellular and molecular mechanisms influencing HCC development. Evidence indicates that the retinoblastoma (RB) pathway is functionally inactivated in most cases of HCC by genetic, epigenetic, and/or viral mechanisms. To investigate the functional relevance of this observation, we inactivated the RB pathway in the liver of adult mice by deleting the three members of the Rb (Rb1) gene family: Rb, p107, and p130. Rb family triple knockout mice develop liver tumors with histopathological features and gene expression profiles similar to human HCC. In this mouse model, cancer initiation is associated with the specific expansion of populations of liver stem/progenitor cells, indicating that the RB pathway may prevent HCC development by maintaining the quiescence of adult liver progenitor cells. In addition, we show that during tumor progression, activation of the Notch pathway via E2F transcription factors serves as a negative feedback mechanism to slow HCC growth. The level of Notch activity is also able to predict survival of HCC patients, suggesting novel means to diagnose and treat HCC.

AB - Hepatocellular carcinoma (HCC) is the third cancer killer worldwide with >600,000 deaths every year. Although the major risk factors are known, therapeutic options in patients remain limited in part because of our incomplete understanding of the cellular and molecular mechanisms influencing HCC development. Evidence indicates that the retinoblastoma (RB) pathway is functionally inactivated in most cases of HCC by genetic, epigenetic, and/or viral mechanisms. To investigate the functional relevance of this observation, we inactivated the RB pathway in the liver of adult mice by deleting the three members of the Rb (Rb1) gene family: Rb, p107, and p130. Rb family triple knockout mice develop liver tumors with histopathological features and gene expression profiles similar to human HCC. In this mouse model, cancer initiation is associated with the specific expansion of populations of liver stem/progenitor cells, indicating that the RB pathway may prevent HCC development by maintaining the quiescence of adult liver progenitor cells. In addition, we show that during tumor progression, activation of the Notch pathway via E2F transcription factors serves as a negative feedback mechanism to slow HCC growth. The level of Notch activity is also able to predict survival of HCC patients, suggesting novel means to diagnose and treat HCC.

KW - Animals

KW - Carcinoma, Hepatocellular

KW - Cell Line

KW - Cell Proliferation

KW - E2F Transcription Factors

KW - Gene Expression Profiling

KW - Humans

KW - Liver Neoplasms

KW - Mice

KW - Mice, Inbred C57BL

KW - Mice, Knockout

KW - Microarray Analysis

KW - Receptors, Notch

KW - Retinoblastoma Protein

KW - Signal Transduction

KW - Stem Cells

KW - Transcription, Genetic

U2 - 10.1084/jem.20110198

DO - 10.1084/jem.20110198

M3 - Journal article

C2 - 21875955

SN - 0022-1007

VL - 208

SP - 1963

EP - 1976

JO - The Journal of Experimental Medicine

JF - The Journal of Experimental Medicine

IS - 10

ER -

Notch signaling inhibits hepatocellular carcinoma following inactivation of the RB pathway

Abstract

Keywords

UN SDGs

Access to Document

Fingerprint

Cite this